BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,826,000 | +18.5% | 303,642 | -0.5% | 0.07% | +15.5% |
| Q2 2022 | $3,229,000 | -41.4% | 305,157 | -10.0% | 0.06% | +13.7% |
| Q1 2022 | $5,512,000 | +16.8% | 339,009 | -0.5% | 0.05% | +88.9% |
| Q4 2021 | $4,720,000 | +4.7% | 340,779 | +8.6% | 0.03% | +17.4% |
| Q3 2021 | $4,509,000 | -9.0% | 313,806 | +0.1% | 0.02% | -4.2% |
| Q2 2021 | $4,955,000 | +130.5% | 313,393 | +48.2% | 0.02% | +100.0% |
| Q1 2021 | $2,150,000 | +5.7% | 211,407 | -64.3% | 0.01% | -7.7% |
| Q3 2020 | $2,034,000 | – | 592,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |